Table 3.

Survival parameters in groups treated with 10 MBq, 20 MBq and 30 MBq of [²²⁵Ac]Ac-DOTA-SP

	10 MBq (n = 4)	20 MBq (n = 10)	30 MBq (n = 7)
PFS [months]	4.5	2.6	2.3
OS-d [months]	18.0	33.0	nd
OS-t [months]	7.0	5.0	nd
OS-r/c [months]	13.0	12.5	nd

nd, not define

PFS, progression-free survival time

OS-d from the first diagnosis of the tumour to death from any cause

OS-t from the start of treatment was defined as the time from the first cycle of [²²⁵Ac]Ac-DOTA-SP treatment to death from any cause

OS-r/c from recurrence or conversion was defined as the time from the diagnosis of recurrence in primary tumours or conversion in secondary, to death from any cause